Compliance Ready Software brings technical controls that comply with 21 CFR Part 11 to the Opentrons Flex. The new offering gives regulated labs an audit-ready automation option with a faster path to deployment and stronger return on investment than enterprise-tier systems. NEW YORK, May 19, 2026 – Opentrons Labworks, Inc.,… Read More
“ “They did something amazing… they took away that scary feeling of ‘I can’t do it’” – Dr. Joeli Marrero, Cold Spring Harbor Laboratory DNA Learning Center, on Opentrons Protocol Designer If you’ve been saving time at the… Read More
New capability lets scientists simulate and visually inspect automated experiments before robots run them Combined simulation and visualization layer bridges AI-generated protocols and real laboratory execution NEW YORK, March 16, 2026 — Before a robotic experiment begins, researchers must understand exactly how the robot will execute each step. Opentrons Labworks,… Read More
When I first started the process of unifying our design system, I remember being more overwhelmed than I’d ever felt in my career. This work was unlike any other process I had undertaken before. I wasn’t even clear on what the end goal needed to be…a three-tiered tokenization structure with… Read More
Opentrons integrates NVIDIA Isaac and NVIDIA Cosmos physical AI software with Opentrons’ global network of 10,000 laboratory robots to enable AI systems that learn from real-world biological experimentation NEW YORK, February 5, 2026 – Opentrons Labworks Inc., a laboratory robotics company enabling AI driven autonomous science, is accelerating the development… Read More
Joint collaboration unites powerful robotics with AI-driven orchestration to redefine how labs scale automation BEVERLY, MA and NEW YORK (February 4, 2026) — HighRes, Inc., a leader in laboratory automation and orchestration software, and Opentrons Labworks, Inc., the leading laboratory robotics company building the physical infrastructure for AI-driven autonomous science,… Read More
Opentrons Robotics Network Infrastructure Becoming Core for AI-Driven Drug Discovery NEW YORK, January 29, 2026 — Opentrons Labworks, Inc., a laboratory robotics company building the physical infrastructure for AI-driven drug discovery, today announced the promotion of James Atwood to Chief Executive Officer. Atwood assumed the role of CEO in… Read More
GlobalBio’s validated, highly diverse human antibody libraries are now available pre-integrated into Neochromosome’s novel neoSwitch™ yeast strain, enabling rapid in-house antibody discovery via yeast display and streamlined lead characterization in secretion mode. LONG ISLAND CITY, N.Y. AND CAMBRIDGE, MA – November 12, 2025 – Neochromosome, Inc., the genome-scale cell engineering… Read More
